Literature DB >> 4943860

Hepatitis-associated antigen hepatitis. An electron microscopic study of virus-like particles in liver cells.

S Huang.   

Abstract

Light and electron microscopic examinations were carried out on liver tissues from 6 renal transplant recipients who developed Australia antigen-associated hepatitis, referred to in this paper as hepatitis-associated antigen (HAA) hepatitis. While under immunosuppressive therapy, the patients showed rapid progression of acute hepatitis to chronic active hepatitis and posthepatitic cirrhosis resulting in liver failure. By electron microscopy, in 5 of 6 patients, characteristic virus-like particles of 230 A size were observed in massive numbers in the nucleus and occasionally in the cytoplasm of liver cells. No similar particles were found in liver biopsies from other patients. These particles had an appearance of nucleocapsid without an outer coat, and were believed to be the viruses in their natural infective states. The predominantly intranuclear location of the particles and the associated nuclear changes suggested that the nucleus is the primary site of virus replication. The finding of the virus-like particles is believed to be diagnostic for HAA hepatitis. While HAA is implicated in serum hepatitis, the identification of HAA with the virus-like particles of this study is still to be established. In the phagosomes, there were some particles showing an outer membrane and a tail-like structure. Both the coated and the noncoated particles were believed to be the same virus. The phagosomes also contained what appeared to be "degradated" viral material. The lysosomal activity in the infected hepatitic cells seemed to be increased. This study showed nonspecific changes of the liver cell nuclei and organelles, probably related to viral infection. The precise mechanism of cell injury remains to be elucidated. However, the result of this study has provided a reasonable basis for future investigations of HAA hepatitis.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4943860      PMCID: PMC2047616     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  A "NEW" ANTIGEN IN LEUKEMIA SERA.

Authors:  B S BLUMBERG; H J ALTER; S VISNICH
Journal:  JAMA       Date:  1965-02-15       Impact factor: 56.272

2.  Organ cultures inoculated with serum from a hepatitis patient with Au antigenemia.

Authors:  A B Jenson; R M McCombs; N Sakurada; J L Melnick
Journal:  Exp Mol Pathol       Date:  1970-10       Impact factor: 3.362

3.  Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.

Authors:  M E Bayer; B S Blumberg; B Werner
Journal:  Nature       Date:  1968-06-15       Impact factor: 49.962

4.  Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders.

Authors:  A Nowoslawski; W J Brzosko; K Madaliński; K Krawczyński
Journal:  Lancet       Date:  1970-03-07       Impact factor: 79.321

5.  Viral hepatitis. New light on an old disease.

Authors:  S Krugman; J P Giles
Journal:  JAMA       Date:  1970-05-11       Impact factor: 56.272

6.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

7.  Ultrastructural variations of nuclear bodies in human diseases.

Authors:  M Bouteille; S R Kalifat; J Delarue
Journal:  J Ultrastruct Res       Date:  1967-08-30

Review 8.  Australia antigen as a hepatitis virus. Variation in host response.

Authors:  B S Blumberg; A I Sutnick; W T London
Journal:  Am J Med       Date:  1970-01       Impact factor: 4.965

9.  Association of virus-like particles with Australia antigen in serum of patients with serum hepatitis.

Authors:  E Zalan; J J Hamvas; B A Tobe; O Kuderewko; N A Labzoffsky
Journal:  Can Med Assoc J       Date:  1971-01-23       Impact factor: 8.262

Review 10.  Hepatitis-associated antigen.

Authors:  N R Shulman
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

View more
  22 in total

1.  Immunohistochemical patterns of hepatitis B surface antigen (HBsAg) in patients with hepatitis, renal homografts recipients and normal carriers.

Authors:  J P Camilleri; C Amat; M Chousterman; J P Petite; A Duboust; A Boddaert; A Paraf
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-12-08

2.  Immunosuppressive therapy and virus-cores in HBAg-positive chronic hepatitis.

Authors:  G Kendrey; A Szalka; B László; L Binder; I Hollós
Journal:  Klin Wochenschr       Date:  1975-11-15

3.  HBs-Ag, HBc-Ag and virus-like particles in liver tissue.

Authors:  S Furuta; A Nagata; K Kiyosawa; T Takahashi; Y Akahane
Journal:  Gastroenterol Jpn       Date:  1975

4.  Cytoplasmic particles in hepatocytes of patients with Australia antigen-positive liver disease.

Authors:  M E Haynes; D W Haynes; R Williams
Journal:  J Clin Pathol       Date:  1972-05       Impact factor: 3.411

Review 5.  Serum hepatitis as a persistent infection.

Authors:  Y E Cossart
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1972

6.  Electron microscope study of a case of Australia antigen-positive chronic hepatitis.

Authors:  J D Almeida; P Gioannini; G Scalise; C V Harrison
Journal:  J Clin Pathol       Date:  1973-02       Impact factor: 3.411

7.  Purification of naked intranuclear particles from human liver infected by hepatitis B virus.

Authors:  S Z Hirschman; M Gerber; E Garfinkel
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

8.  Hepatitis in mice infected with Coxsackie virus B 1 .

Authors:  G E Burch; C Y Tsui; J M Harb
Journal:  Br J Exp Pathol       Date:  1973-06

Review 9.  Recent advances in the identification of hepatitis viruses.

Authors:  J L Dienstag; R H Purcell
Journal:  Postgrad Med J       Date:  1977-07       Impact factor: 2.401

10.  Application of electron microscopy in viral diagnosis.

Authors:  E Kjeldsberg
Journal:  Pathol Res Pract       Date:  1980-05       Impact factor: 3.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.